1. 83POlaparib plus paclitaxel sensitivity in biomarker subgroups of gastric cancer. (23rd October 2018) Authors: Liu, Y-Z; Hodgson, D; Locker, G; Lai, Z; Balcerzak, D; Sharpe, A; Barrett, J C; Orr, M; Gutjahr, T S; Dougherty, B; Roudier, M P; Shi, X; Miller, R; Kim, W H; Zeng, X; Ochiai, A; Im, S-A; Xu, R-H; Boku, N; Bang, Y-J Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Atypical adenomatous hyperplasia of the lung: a clinicopathological study of 118 cases including cases with multiple atypical adenomatous hyperplasia. Issue 4 (1st April 2001) Authors: Nakahara, R; Yokose, T; Nagai, K; Nishiwaki, Y; Ochiai, A Journal: Thorax Issue: Volume 56:Issue 4(2001) Page Start: 302 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinicopathological differences between colonic and rectal carcinomas: are they based on the same mechanism of carcinogenesis?. Issue 6 (1st December 1999) Authors: Konishi, K; Fujii, T; Boku, N; Kato, S; Koba, I; Ohtsu, A; Tajiri, H; Ochiai, A; Yoshida, S Journal: Gut Issue: Volume 45:Issue 6(1999) Page Start: 818 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P-034PARADIGM study: A multicenter, randomized, phase III study of mFOLFOX6 plus panitumumab or bevacizumab as first-line treatment in patients with RAS (KRAS/NRAS) wild-type metastatic colorectal cancer. (2nd July 2019) Authors: Muro, K; Uetake, H; Tsuchihara, K; Shitara, K; Yamazaki, K; Ota, M; Oki, E; Sato, T; Naitoh, T; Komatsu, Y; Kato, T; Yamanaka, K; Mori, I; Soeda, J; Hihara, M; Yamanaka, T; Akagi, K; Ochiai, A; Yoshino, T Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗